The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in ...

Mar. 20, 2025 — Though we learn so much during our first years of life, we can't, as adults, remember specific events from that time. Researchers have long believed we don't hold onto these ...

By studying the effects of the nasal anti-CD3 in a ... The Brain Perceives Unexpected Pain More Strongly Feb. 21, 2025 — Researchers used visual threat manipulation in the virtual reality ...

Shares of Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) have been given a consensus recommendation of “Buy” by ...

Context Therapeutics Inc.’s CNTX share price has dipped by 11.07%, which has investors questioning if this is right time to buy.